TWI832920B - 抑制軟性隱形眼鏡變質之眼科用組成物 - Google Patents

抑制軟性隱形眼鏡變質之眼科用組成物 Download PDF

Info

Publication number
TWI832920B
TWI832920B TW108139295A TW108139295A TWI832920B TW I832920 B TWI832920 B TW I832920B TW 108139295 A TW108139295 A TW 108139295A TW 108139295 A TW108139295 A TW 108139295A TW I832920 B TWI832920 B TW I832920B
Authority
TW
Taiwan
Prior art keywords
ophthalmic composition
salt
soft contact
acid
epinastine
Prior art date
Application number
TW108139295A
Other languages
English (en)
Chinese (zh)
Other versions
TW202031263A (zh
Inventor
森本隆司
稻垣孝司
小川敏弘
桃川雄介
Original Assignee
日商參天製藥股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日商參天製藥股份有限公司 filed Critical 日商參天製藥股份有限公司
Publication of TW202031263A publication Critical patent/TW202031263A/zh
Application granted granted Critical
Publication of TWI832920B publication Critical patent/TWI832920B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C13/00—Assembling; Repairing; Cleaning
    • G—PHYSICS
    • G02—OPTICS
    • G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
    • G02C7/00—Optical parts
    • G02C7/02—Lenses; Lens systems ; Methods of designing lenses
    • G02C7/04—Contact lenses for the eyes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Optics & Photonics (AREA)
  • General Physics & Mathematics (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Eyeglasses (AREA)
TW108139295A 2018-10-31 2019-10-30 抑制軟性隱形眼鏡變質之眼科用組成物 TWI832920B (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2018205215A JP2019108320A (ja) 2018-10-31 2018-10-31 ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP2018-205215 2018-10-31

Publications (2)

Publication Number Publication Date
TW202031263A TW202031263A (zh) 2020-09-01
TWI832920B true TWI832920B (zh) 2024-02-21

Family

ID=67178967

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108139295A TWI832920B (zh) 2018-10-31 2019-10-30 抑制軟性隱形眼鏡變質之眼科用組成物

Country Status (4)

Country Link
JP (3) JP2019108320A (cg-RX-API-DMAC7.html)
CN (3) CN119258073A (cg-RX-API-DMAC7.html)
TW (1) TWI832920B (cg-RX-API-DMAC7.html)
WO (1) WO2020090895A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7118579B1 (ja) 2020-04-16 2022-08-16 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP6963651B2 (ja) * 2020-04-16 2021-11-10 参天製薬株式会社 エピナスチン又はその塩を含有する水性組成物
JP7114668B2 (ja) * 2020-10-08 2022-08-08 参天製薬株式会社 エピナスチン又はその塩を含有する花粉破裂抑制剤
WO2022138842A1 (ja) * 2020-12-24 2022-06-30 参天製薬株式会社 エピナスチン又はその塩と硫黄系抗酸化剤を含有する経皮投与用医薬組成物
CN113608363B (zh) * 2021-08-24 2023-04-14 江苏康耐特光学有限公司 一种制备高折射率树脂镜片的前弯弯度设计方法
JP2023166315A (ja) * 2022-05-09 2023-11-21 ロート製薬株式会社 眼科組成物
CN120282788A (zh) 2022-12-23 2025-07-08 参天制药株式会社 提高组织迁移性及防腐效力的含有依匹斯汀的水性组合物

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
WO2007088783A1 (ja) * 2006-02-02 2007-08-09 Menicon Co., Ltd. ソフトコンタクトレンズ用点眼・装着液
WO2015152155A1 (ja) * 2014-03-31 2015-10-08 ロート製薬株式会社 眼科用又は耳鼻科用水性組成物
JP7324566B2 (ja) * 2015-05-28 2023-08-10 ロート製薬株式会社 水性眼科組成物
JP6134853B1 (ja) * 2016-10-28 2017-05-24 参天製薬株式会社 エピナスチン含有点眼液
JP6971570B2 (ja) * 2016-12-26 2021-11-24 小林製薬株式会社 花粉破裂抑制剤
JP6940276B2 (ja) * 2016-12-26 2021-09-22 小林製薬株式会社 花粉破裂抑制剤
JP7313181B2 (ja) 2018-04-23 2023-07-24 ロート製薬株式会社 眼科組成物
JP7382731B2 (ja) 2018-04-23 2023-11-17 ロート製薬株式会社 眼科組成物
JP7355539B2 (ja) * 2018-07-20 2023-10-03 ロート製薬株式会社 眼科組成物
JP7458159B2 (ja) * 2018-09-28 2024-03-29 ロート製薬株式会社 眼科組成物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
專書 参天製薬株式会社 アレジオン点眼液0.05%「ALESION Ophthalmic Solution 0.05%」藥品說明書 2017年11月改訂
期刊 杉尾嘉宏等 エピナスチン塩酸塩点眼液の薬理作用と臨床成績 アレルギーの臨床 36(8) 2016 43-51

Also Published As

Publication number Publication date
JP2020070301A (ja) 2020-05-07
CN119236081A (zh) 2025-01-03
WO2020090895A1 (ja) 2020-05-07
JP7429681B2 (ja) 2024-02-08
CN112969465B (zh) 2024-10-25
JP2022022379A (ja) 2022-02-03
JP6992033B2 (ja) 2022-01-13
JP2019108320A (ja) 2019-07-04
CN112969465A (zh) 2021-06-15
CN119258073A (zh) 2025-01-07
TW202031263A (zh) 2020-09-01

Similar Documents

Publication Publication Date Title
JP7429681B2 (ja) ソフトコンタクトレンズの変質を抑制する眼科用組成物
CA2807084C (en) Preservative free brimonidine and timolol solutions
JP2024116303A (ja) 点眼剤
JP7199146B2 (ja) ブリモニジン及びチモロールの固定用量合剤
WO2014008542A1 (en) Compositions, methods and/or devices for prevention and/or treatment of dry eye disorders
MX2011009802A (es) Formulaciones oftalmicas de cetirizina y metodos de uso.
JP2013534527A (ja) コンタクトレンズ乳頭結膜炎及びアレルギー性眼疾患の予防及び処置のための組成物
MX2014012158A (es) Composicion farmaceutica de ibuprofeno y tramadol para uso oftalmico.
WO2016060917A2 (en) Formulations for histatin therapeutics
JP7247278B2 (ja) 水性医薬組成物
JP6449774B2 (ja) 両性イオン性ソフトコンタクトレンズ用眼科用組成物
JP7628098B2 (ja) エピナスチン又はその塩を含有する花粉破裂抑制剤
JP2020070297A (ja) ソフトコンタクトレンズの変質を抑制する眼科用組成物
JP2016034936A (ja) 角膜上皮障害治療剤の組み合わせ
WO2024135837A1 (ja) 組織移行性及び防腐効力を向上させるエピナスチン含有水性組成物